SEC Form 4 · accession 0001179110-15-009972

AMAG PHARMACEUTICALS INC. · AMAG

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — SVP, Finance and Treasurer

Period of report

Jun 15, 2015

Accepted (ET)

Jun 17, 2015 · 5:18 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000792977

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Jun 15, 2015	S	1,346	$66.63	D	51,958	D
Common Stock	Jun 15, 2015	M	2,734	$14.89	A	54,692	D
Common Stock	Jun 15, 2015	M	3,500	$16.55	A	58,192	D
Common Stock	Jun 15, 2015	S	6,234	$66.63	D	51,958	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Option (Right to Buy)^F2	$14.89	Jun 15, 2015	M	2,734	A	—	Jun 25, 2019	Common Stock	2,734	14,375	D
Stock Option (Right to Buy)^F3	$16.55	Jun 15, 2015	M	3,500	A	—	Feb 28, 2023	Common Stock	3,500	11,500	D

F1The reported transactions on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 4, 2015.
F2This option vests and becomes exercisable over four years from the grant date (June 25, 2012), with 25% vesting on the first anniversary of the grant date and the remainder vesting in equal quarterly installments over the next three years thereafter.
F3This option vests and becomes exercisable over four years from the grant date (February 28, 2013), with 25% vesting on the first anniversary of the grant date and the remainder vesting in equal quarterly installments over the next three years thereafter.